Search

Author/Creator Hogg, David

4. Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial. Issue 4 (April 2017)

Authors:
Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Arance, Ana; Dutriaux, Caroline; Di Giacomo, Anna Maria; Rutkowski, Piotr; Del Vecchio, Michele; Gutzmer, Ralf; Mandala, Mario; Thomas, Luc; Demidov, Lev; Garbe, Claus; Hogg, David; Liszkay, Gabriella; Queirolo, Paola; Wasserman, Ernesto; Fo...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 4(2017:Apr.)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy. Issue 1 (22nd January 2021)

Authors:
Rose, April A N; Armstrong, Susan M; Hogg, David; Butler, Marcus O; Saibil, Samuel D; Arteaga, Diana P; Pimentel Muniz, Thiago; Kelly, Deirdre; Ghazarian, Danny; King, Ian; Kamil, Zaid Saeed; Ross, Kendra; Spreafico, Anna
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cancer patients' experiences with immune checkpoint modulators: A qualitative study. (2nd March 2020)

Authors:
Ala‐Leppilampi, Kari; Baker, Natalie A.; McKillop, Chris; Butler, Marcus O.; Siu, Lillian L.; Spreafico, Anna; Abdul Razak, Albiruni R.; Joshua, Anthony M.; Hogg, David; Bedard, Philippe L.; Leighl, Natasha; Oza, Amit M.; Parsons, Janet A.; Hansen, Aaron R.
Journal:
Cancer medicine
Issue:
Volume 9:Number 9(2020)
Page Start:
3015
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Issue 7 (July 2017)

Authors:
Davies, Michael A; Saiag, Philippe; Robert, Caroline; Grob, Jean-Jacques; Flaherty, Keith T; Arance, Ana; Chiarion-Sileni, Vanna; Thomas, Luc; Lesimple, Thierry; Mortier, Laurent; Moschos, Stergios J; Hogg, David; Márquez-Rodas, Iván; Del Vecchio, Michele; Lebbé, Céleste; Meyer, Nicolas; Zhang, Y...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 7(2017:Jul.)
Page Start:
863
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy. (7th November 2013)

Authors:
Nguyen, Linh T; Butler, Marcus O; Yen, Pei Hua; Nie, Jessica; Pniak, Michael; Elford, Alisha R; Joshua, Anthony M; Hogg, David; Ghazarian, Danny; Al-Habeeb, Ayman; Easson, Alexandra M; Leong, Wey L; McCready, David R; Reedijk, Michael; Messner, Hans A; Ohashi, Pamela S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT‐ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs. Issue 7 (8th January 2020)

Authors:
Hansen, Aaron R.; Ala‐Leppilampi, Kari; McKillop, Chris; Siu, Lillian L.; Bedard, Philippe L.; Abdul Razak, Albiruni R.; Spreafico, Anna; Sridhar, Srikala S.; Leighl, Natasha; Butler, Marcus O.; Hogg, David; Sacher, Adrian; Oza, Amit M.; Al‐Agha, Rany; Maurice, Catherine; Chan, Christopher T.; Sh...
Journal:
Cancer
Issue:
Volume 126:Issue 7(2020)
Page Start:
1550
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗